CD274 and head and neck squamous cell carcinoma: <b>Conclusions</b>: Our findings highlight variability in PD-L1 expression in HNSCC and may offer context for differential responses of primary tumors and lymph node metastases to immune checkpoint therapy reported in recent clinical studies.